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MesenchymalAbstract Human embryonic stem cells (hESCs) have the ability to differentiate into all human
cells, however controlling the differentiation has always been a challenge. In the present study
we have investigated the direct differentiation of hESCs on MEFs by using TGF-b signaling path-
way activators Activin A and Activin B. Activation of the TGF-b pathway with Activin B in low
serum highly induced primitive streak and mesendoderm formation after 24 h, which included up-
regulation of SOX 17 and BRACHYURY protein and gene expression. Continuous stimulation
with Activin B in 2% serum further induced mesendoderm formation by increased gene expression
of Brachyury, SOX17, MEOX and FOX at the same time we found down-regulation of neu-
roectodermal marker genes. Further, by stimulating the mesodermal cells by BMP-2 we succeeded
to induce mesenchymal like cells with high expression of mesenchymal markers including; MEOX,
FOX, RUNX2, COL1 and OSTEOPONTIN. In conclusion we have directed the differentiation of
hESCs as monolayer to primitive streak like cells with Activin B and further into pure mesoderm
and mesenchymal like cells by BMP-2.
ª 2015 TheAuthors. Production and hosting by Elsevier B.V. on behalf ofKing SaudUniversity. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Mesoderm is the middle germ layer during embryonic develop-
ment, and vertebrate mesoderm produces a wide range of tis-
sues including, the muscle, and the circulatory system
including the heart, vasculature, hematopoietic system, kidney,
gonads, dermis, cartilage and the bones. In lower vertebrates,
it is well known that deﬁnitive endoderm and mesoderm cells
arise from a common bi-potent mesendoderm progenitor.
Recently, it has been suggested that such a mesendoderm
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2002; Rodaway and Patient, 2001; Tada et al., 2005). There
are some essential signaling pathways in gastrulation and
primitive streak formation that are activated by growth factors
such as Nodal, BMP/TGF-b and WNT for initiation of
gastrulation (Park, 2011; Sowa et al., 2002). Ligands for the
signaling pathways are also expressed in the primitive streak
(PS) and node, which is essential for the accurate mesoderm
and deﬁnitive endoderm development (Wolfe and Downs,
2014).
Monolayer human ESC differentiation is the simplest
approach for direct differentiation. hESCs grown either on
feeders or feeder free layers (using a matrix) can be induced
to differentiate into speciﬁc lineages (Bauwens et al., 2008;
Cameron et al., 2006; Keller, 2005; van den Berg et al.,
2015). Differentiation on known substrates can minimize the
inﬂuence of neighboring cells so that the true effect of growth
factors/cytokines can be measured (Yao et al., 2006). A study
from the group of Kevin D’Amour has shown that stimulation
of TGF-b signaling by Activin induction promotes hESC dif-
ferentiation into deﬁnitive endoderm through a transition state
of primitive streak when grown as a monolayer (D’Amour
et al., 2005). In their study they demonstrated that removal
of Activin and introduction of serum after 3 days of stim-
ulation gave rise to mesoderm and inhibited endoderm dif-
ferentiation. To examine their procedure for mesodermal
differentiation we aimed to differentiate hESCs as a monolayer
in the presence of Activin for induction of primitive streak
formation.
2. Materials and methods
2.1. Culturing of undifferentiated hESC cells
All tissue culturing was carried out using the sterile technique
under laminar ﬂow conditions. Cells were grown at 37 C in an
atmosphere of 5% CO2 and a relative humidity of 90–100%.
The undifferentiated hESC cell line used during this study
was HUES9, which was obtained from Howard Hughes
Medical Institute, Harvard University. Undifferentiated
hESC cells were maintained on a feeder layer of mitotically
inactivated mouse embryonic ﬁbroblast (MEF) cells in
Knockout Dulbecco’s Modiﬁed Eagle’s Medium (KO-
DMEM) (Invitrogen) supplemented with 15% Knockout
Serum Replacement (KO-SR) (Invitrogen), 0.5% human
serum albumin (ZLB Behring), 0.1 mM b-mercaptoethanol
(Sigma), 1% MEM non-essential amino acids solution
(Invitrogen), 2 mM glutamine as Glutamax-I (Invitrogen),
50 units/ml penicillin and 50 lg/ml streptomycin (Invitrogen),
and 5–10 ng/ml recombinant human basic ﬁbroblast growth
factor (bFGF) (Invitrogen). Before plating of cells, tissue cul-
ture plates (Nunc) were coated with 0.1% gelatine (Sigma) for
approximately 30 min at room temperature (RT). The MEF
cells were expanded in KO-DMEM supplemented with 10%
fetal bovine serum (FBS) (PAA), 2 mM Glutamax-I,
50 units/ml penicillin, and 50 lg/ml streptomycin. MEF cells
were mitotically inactivated by c-irradiation. Prior to inactiva-
tion, the MEF cells were washed once with D-PBS/
(Invitrogen) chelating Mg2+ and Ca2+ from adhesive proteins
followed by enzymatic dissociation with 0.05% trypsin with
0.53 mM EDTA (Invitrogen) for 1–2 min at 37 C. Trypsinwas removed and inactivation was carried out by c-irradiation
for 15 min at 266.7 rads/min. The MEF cells were stored in
vials of 1.5 · 106 and 5 · 106 cells in 0.5 ml freeze media
(90% MEF media and 10% dimethyl sulfoxide (DMSO)
(Sigma)) at 150 C.
One day in advance of passaging the hESC cells, plates with
MEFs were prepared by seeding 20,000 cells/cm2 MEF cells
onto gelatin pre-coated plates. The MEF cells were allowed
to attach for approximately 24 h, after which media was chan-
ged to hESC media for at least 3–4 h or overnight (O.N.) for
conditioning hESC media. Human ESC colonies were pas-
saged at 1:3–1:6 split ratio every 4–7 days by trypsinization.
When cultures reached sub-conﬂuence, the colonies were
gently washed with PBS/ and 0.05% trypsin/EDTA was
added. The detachment was observed under the microscope.
When the MEF cells had rounded up and mostly detached,
trypsin was aspirated and pre-warmed hESC media was added
to the colonies. Human ESC colonies were scraped off the
dishes and gently pipetted up and down to break up large
clumps containing 50–100 cells. Subsequent cell suspension
was transferred to the pre-prepared MEF culture plates con-
taining conditioned hESC media. In between split days, a half
media change was performed every day.
2.2. Monolayer differentiation of hESCs to mesenchymal cells
Human ESCs were differentiated into deﬁnitive mesendoderm
cells as monolayer. The differentiation protocol was derived
from D’Amour et al. (2005). Differentiation was carried out
in RPMI 1640 media (Invitrogen), supplanted with 2 mM
Glutamax-1, 1% penicillin/streptomycin, and FBS at concen-
trations ranging from 0.5% to 2.0%. To induce mesendoderm
differentiation 100 ng/ml of human Activin A or B was added
to differentiation media. When hESC cultures reached
approximately a conﬂuency of 80–90%, differentiation was
initiated. Before replacing media with differentiation media,
the cells were gently washed twice with PBS+/+ to remove
any growth factors bound to cell surface receptors. For the
ﬁrst 24 h, differentiation media with 0.5% FBS were used.
The subsequent 24–96 h of differentiation cells were cultured
with 2.0% FBS. To promote mesenchymal formation, 72 h
of pre-differentiated mesendoderm cells were subjected to
100 ng/ml of human recombinant BMP2 (R&D) for additional
6–9 days.
2.3. RNA extraction, reverse transcription and real-time PCR
Total RNA from cell samples was isolated using the TRIZOL
method according to the manufacturer’s instructions. RNA
quantitation was determined using a NanoDrop ND-1000
Spectrophotometer (NanoDrop). cDNA was synthesized from
1 to 2 mg of total RNA using a commercial revertAid H minus
ﬁrst strand cDNA synthesis kit (Fermentas) according to the
manufacturer’s instructions. Real-time qPCR was performed
on a MyiCycler thermal cycler (Bio-Rad, Copenhagen,
Denmark) using iQ SYBR Green mastermix (Bio-Rad)
according to the manufacturer’s instructions. Quantiﬁcation
of target and reference genes (b-actin) was performed in dupli-
cate. Following normalization to the b-actin gene, expression
levels for each target gene were calculated using the compara-
tive threshold cycle (CT) method (1/2DCT, where DCT is the
Figure 1 Experimental procedure for directing the differentia-
tion of hESCs toward a mesendodermal population and further
into mesoderm. Differentiation of hESCs through a process that
closely recapitulates gastrulation can be orchestrated by the
application of high dose of Activin B in the context of low serum.
Maximal expression of primitive streak-expressed genes (MEOX1,
BRACH) occurs at 24–36 h. If maintained in high dose Activin B,
the cells are efﬁciently converted into deﬁnitive endoderm cells
expressing SOX17. In contrast, if exogenous Activin B is removed
and BMP-2 added cells express mesoderm/mesenchymal markers
(FOXF1, MEOX1, RUNX2, OP and COL-1).
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analyzed using the Optical System Software Version 3.1
(Bio-Rad) and Microsoft Excel 2000 (Seattle, WA, USA) to
generate relative expression values. Primers used in this study
are listed below with employing an annealing temperature of
60 C. Data are presented as the mean ± SD from three
independent experiments. Primers used were OCT4: forward
GAAGGTATTCAGCCAAAC, reverse CTTAATCCCAAA
AACCCTG, SOX17: forward CAGCAGAATCCAGACCT
GCA, reverse GTCAGCGCCTTCCACGACT, MEOX1: for-
ward AATCATCCAGGCGGAGAAA, reverse AAGGCCG
TCCTCTCCTTG, FOXF-1: forward CAGCCTCTCCACG
CACTC, reverse CCTTTCGGTCACACATGCT, NEUROD1:
forward CTTGGCCAAGAACTACATCTGG, reverse GGA
GTAGGGATGCACCGGGAA, BRACHYURY: forward
GAAGGTGGATCTCAGGTA GCG and reverse CGCAG
CTGGGCGCCTGCGGCT.
2.4. Immunocytochemical staining
For immunostaining, cells were grown to 80–90% conﬂuence
on 2-, 4- and 8-well Permanox chamber slides (Nunc,
Roskilde, Denmark). The slides were ﬁxed in 4% formalde-
hyde for 10 min and then washed three times in PBS/.
Nonspeciﬁc immunoglobulin G binding sites were blocked
for 20 min with 5% bovine serum albumin (BSA) in PBS or
serum-free block solution (Zymed, San Francisco, CA).
Primary, as well as secondary antibodies, were diluted in 2%
BSA dissolved in PBS. Cells were incubated with primary
antibodies for 60 min, antibodies used were goat anti-human
Brachyury (R&D, 1:100) and goat anti-Human Sox 17
(R&D, 1:400). Unbound antibody was removed by 3 · 2 min
of washing with TBS, before biotinylated secondary antibody
was added for 10 min allowing it to bind speciﬁcally to the
Fc domain of the primary antibody. Unbound antibody was
removed by rinsing 3 · 2 min with TBS, followed by incuba-
tion with streptavidin–peroxidase conjugate for 10 min, result-
ing in the formation of biotin/streptavidin complex. Cells were
again rinsed 3 · 2 min with TBS, after which the chromogen,
AEC Substrate (Zymed), was added. The AEC (aminoethyl
carbazole) chromogen was incubated with the cells for
3–5 min, until adequate color development was seen. The
peroxidase color reaction was halted by washing twice with
distilled water. Counter staining of the nucleus was carried
out by hematoxylin staining for 30 s. Cells were again rinsed
twice with distilled water and ﬁnally mounted with Aquatex.
2.5. Statistical analysis
All results are presented with the standard deviation (SD) of at
least 3 independent experiments. Two-tailed Student’s t-tests
were used for testing differences between groups. P values
<0.05 were considered signiﬁcant.
3. Results and discussion
Using deﬁned conditions Kubo et al. were the ﬁrst to show
that mESC differentiated into deﬁnitive endoderm by culturing
them in the presence of Activin A under serum free conditions.
Furthermore, they were able to show that the endoderm cells
developed from a bi-potent BRACYURY+ mesendodermpopulation which, in turn, were able to give rise to both deﬁni-
tive endoderm and mesoderm (Kubo et al., 2004).
Furthermore, a recent study has shown that induction of
mesoderm progenitor cells by BMP-2 enhances osteogenic dif-
ferentiation (Ponce et al., 2008), and mESCs respond to BMP2
stimulation and differentiate into osteo-, chondro and adi-
pogenic lineages (Zur Nieden et al., 2005). In order to investi-
gate whether the hESCs are able to differentiate into primitive
streak-like cells in vitro in response to Activin treatment and
further to differentiate into mesoderm in response to BMP-2
treatment, we applied the differentiation protocol as described
by D’Amour and colleagues with some modiﬁcations (Fig. 1).
Conﬂuent undifferentiated hESCs were grown as colonies on
inactivated MEF cells, the differentiation was initiated by
changing growth media to RPMI based serum free media with
continuous exposure to 100 ng/ml Activin B for 5 days (out-
lined in Fig. 1). We have previously shown that Activin B is
a much more potent inducer of primitive streak and endoderm
than Activin A in the 3-D embryoid formation differentiation
model (Frandsen et al., 2007), therefore Activin B was used
throughout the study. During monolayer differentiation we
observed that the cell line we used, HUES9, reacted differently
to stimulation from Activin A or B. Activin A did not induce
BRACHYURY gene expression, whereas Activin B showed
high BRACHYURY and SOX17 gene expression (Fig. 2).
Therefore, we determined to continue the use of Activin B
for further differentiation. For the ﬁrst 24 h RPMI media
was supplemented with 0.5% FBS and the following 4 days
of differentiation were carried out in 2.0% FBS. Cells cultured
in RPMI media with no Activin B were included as controls.
Three days of induction with Activin B enhances endoderm
and mesoderm marker expression. During the ﬁrst day of
treatment cells started to detach, and after 2–3 days, massive
cell death was observed. At 3 days of Activin B treatment, cells
with a ﬂat, cobblestone-like appearance emerged beneath the
Figure 2 Immunostaining revealing the difference between Activin A and B on mesendoderm differentiation. Human ESCs were
differentiated in the presence of 100 ng/ml of either Activin A or B or 72 h in RPMI media containing 0.5% FBS for the initial 24 h and
2% for rest of the differentiation period. A matched control is included without any stimulation. Cells were stained with antibodies speciﬁc
for SOX17 and brachyury (BRACH), original magniﬁcation is 100·.
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the culture dishes. After 5 days of Activin B treatment, cell cul-
tures were composed of a very homogeneous population with
relatively large cobblestone-like cells, which appeared to be
very similar to hepatocytes. In the non-treated control cul-
tures, massive detachment of cells was also observed during
the ﬁve days of induction, however, no cells with cobble-
stone-like morphology were observed (Fig. 3A).
Activin B stimulation of hESCs in media containing a low
percentage of serum initiated differentiation of the cells, 24 h
after stimulation the cells started to express the primitive
streak and mesoderm marker BRACHYURY and the endo-
derm marker SOX17, although fewer cells expressed SOX17
than BRACHYURY. The expression of both markers
increased gradually, and expression of BRACHYURY
reached its maximum at 36 h of Activin B treatment, hereafter
the expression level decreased even though continuous Activin
B stimulation was continued. Conversely, SOX17 protein
expression increased until ﬁve days of Activin B induction
(Fig. 2A). Gene expression analysis demonstrated that the
pluripotency marker Oct4 was rapidly down regulated in
serum free media. However, when cells were stimulated with
Activin B they did not show the same level of OCT4 down-reg-
ulation. Recent papers have indicated that activation of
Activin/Nodal signaling is important for the maintenance of
the pluripotent state of hESCs (James et al., 2005; Vallier
et al., 2005); these data could demonstrate why a late down-
regulation of Oct-4 was seen in Activin stimulated monolayer
cultures. Furthermore, gene expression analysis showed consis-
tent agreement with immunostaining analysis with a gradual
increase in BRACHYURY expression reaching a maximum
at day 3, and again, SOX17 expression showed a maximum
level of expression after 5-days of Activin B induction
(Fig. 2B). The early mesoderm marker MEOX1 (Candia
et al., 1992) was shown to be highly induced by Activin B
induction for the ﬁrst 3 days, hereafter the expression level
decreased dramatically, concurrently a later mesodermmarker, FOXF1, was only seen to be expressed at day 3 with
the expression level decreasing at day 5 (Fig. 2B). To look
for neuroectodermal differentiation, we monitored the expres-
sion of the early ectoderm marker NEUROD1, this was only
expressed at day 3 under the control conditions (Fig. 2B), indi-
cating no contamination of ectodermal lineages in Activin B
induced cells.3.1. Effect of BMP2 stimulation on monolayer primitive streak
cell population
At this point hESCs could be differentiated into a mesendo-
derm population that expressed early and late mesoderm mar-
kers; we then endeavored to investigate the effect of BMP-2 on
this mesendodermal cell population as a method of differentia-
tion toward an osteogenic lineage. Effect of BMP-2 was tested
on hESC-derived mesendodermal cells in low serum medium.
We added BMP2 at day 3 of differentiation in low serum media
to the cells. The cells were analyzed after an additional 3–6 days
of culture for osteogenic markers. Stimulation with BMP2 for
6 days did not change the morphology of the cells, however
slight increases in the expression level of osteogenic genes were
observed. We found that induction with BMP2 repressed
SOX17 gene expression and induced the expression of both lat-
eral plate mesoderm marker (FOXF1) and paraxial mesoderm
marker (MEOX1) in the differentiated hESCs (Kalinichenko
et al., 2001). As expected, we observed an increase in gene
expression of osteogenic markers such as, RUNX2, OP and col-
lagen 1 (Col-1), however other osteogenic and chondrogenic
markers such as MSX2, ALP, DLX5, SOX9 and OSX, among
others, were not affected by BMP2 induction. We tested the
osteogenic and adipogenic differentiation abilities of these cells
by sub-culturing them on ﬁbronectin coated culture plates in
osteogenic and adipogenic media. However, these cells did
not show any potentiality in differentiation toward osteogenic
or adipogenic lineages (data not presented).
Figure 3 Analysis of direct monolayer differentiated hESCs to mesendoderm like population. (A) Upper panel showing representative
light microscope images for monolayer differentiation of hESCs in the presence or absence of Activin B (100 ng/ml). Lower panel shows
immunostaining of differentiated hESCs with mesendoderm marker brachyury (BRACH) endoderm marker SOX17 (original
magniﬁcation 100·). (B) Total RNA was extracted and real time-PCR analysis was performed on the undifferentiated HUES9 hESCs
(ESC), differentiated cells without Activin B induction (control) and differentiated in the presence of 100 ng/ml of Activin B (A 100) for 1,
3 and 5 days (1, 3, 5). Expression levels of target genes are represented as fold induction over undifferentiated hESCs, values are
represented as mean ± SD of three independent experiments. *P< 0.05 and **P< 0.005 versus ESC. (C) Real-time PCR analysis on
mesodermal and osteogenic genes in day 3 Activin B induced mesendoderm cells (3) 100 ng/ml of BMP2 induced for additional 3 days
(B-3) and 6 days (B-6). The expression level of each target gene was normalized to b actin and presented as mean of three independent
experiments.
696 A. Mahmood, A. Aldahmash4. Conclusion
Taken together these results have demonstrated a protocol for
directing differentiation of hESCs through the gastrulation
step of primitive streak formation into a deﬁnitive mesendo-
dermal stage by monolayer differentiation in low serum media.
In order to investigate the developmental potential of the
derived mesendoderm cells differentiated by Activin B into a
more mesodermal/mesenchymal direction we stimulated the
cells using BMP2, which has been shown to be necessary for
paraxial mesoderm development (Miura et al., 2006;
Mendjan et al., 2014). Later in the development BMP2 also
plays an essential role in osteogenic induction of mesenchymalcells (Matsubara et al., 2008). BMP2 induced cells were shown
to express some of the mesenchymal/osteogenic markers but
failed to express the majority of markers, furthermore the mor-
phology of the cells did not change, it maintained to be as a
squamous epithelial like morphology. In conclusion, it was
not possible to differentiate mesendodermal cells further into
a mesenchymal phenotype in a monolayer cell culture.Conﬂict of interest
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